CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT07464951 · RECRUITING

Trial details

NCT number: NCT07464951
Sponsor: Stephan Grupp MD PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2026-05-14
Primary completion: 2029-05-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.